Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphoma

BACKGROUND: Patients with common variable immunodeficiency (CVID) have an increased risk of developing lymphoproliferative diseases, including non-Hodgkins lymphoma (Blood 116:1228–1234, 2010; Blood 119:1650–7, 2012). The incidence and prognosis of Hodgkin lymphoma in this population is not clear, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rael, Efren, Rakszawski, Kevin, Koller, Kristian, Bayerl, Michael, Butte, Manish, Zheng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785670/
https://www.ncbi.nlm.nih.gov/pubmed/26966541
http://dx.doi.org/10.1186/s40364-016-0061-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785670/
https://www.ncbi.nlm.nih.gov/pubmed/26966541
http://dx.doi.org/10.1186/s40364-016-0061-8

Ejemplares similares